C12N 2710/24232
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2710/24232 (Use of virus as therapeutic agent, other than vaccine) appears on 7 US grants and 13 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 13
- Assignees
- 6
- Inventors
- 41
- Latest grant
- 22 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oncolytic virus expressing a car T cell target and uses thereof22 Jul 2025US 12,364,724 B2City of Hope
- Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident18 Mar 2014US 8,673,934 B2
- Parapoxviruses in combination with other antiviral agents for the treatment of viral diseases1 Jan 2013US 8,343,478 B2AiCuris GmbH & Co. KG
- Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer1 Mar 2011US 7,897,159 B2AiCuris GmbH & Co. KG
- Methods of treating viral infections3 Feb 2004US 6,685,950 B2Bayer Aktiengesellschaft
- Pharmaceutical composition for treating a brain tumor23 Jul 2026US 2026/0207692 A1Patentpool Target GmbH
- Oncolytic virus expressing a car t cell target and uses thereof18 Dec 2025US 2025/0381237 A1City of Hope
- Mutant orf viruses and uses thereof19 Jun 2025US 2025/0197815 A9Suzhou Prajna Biotech Co., Ltd.
- Mutant orf viruses and uses thereof26 Oct 2023US 2023/0340424 A1Suzhou Prajna Biotech Co., Ltd.
- Parapoxvirus for conditioning for and treatment of coronavirus infections22 Dec 2022US 2022/0401553 A1AiCuris GmbH & Co. KG
Most cited
By later US patents
- Methods of treating viral infections11US 6,685,950 B2Bayer Aktiengesellschaft · 2004
- Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer10US 7,897,159 B2AiCuris GmbH & Co. KG · 2011
- Indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses3US 6,162,600 A2000
- Use of strains of parapoxvirus ovis against organ fibrosis3US 6,632,647 B2Bayer Aktiengesellschaft · 2003